Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hartigan-O'Connor

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Neurology|August 27, 2002
Progress toward gene therapy of Duchenne muscular dystrophyD Hartigan-O'Connor, J S Chamberlain
Microscopy Research and Technique|February 19, 2000
Developments in gene therapy for muscular dystrophyD Hartigan-O'Connor, J S Chamberlain
Journal of Virology|August 10, 1999
Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymeraseD Hartigan-O'Connor, A Amalfitano, J S Chamberlain
Cancer Research|December 26, 2001
The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodallyC J Kirk, D Hartigan-O'Connor, J J Mulé
Journal of Virology|February 23, 2000
Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stagesN H Shin, D Hartigan-O'Connor, J K Pfeiffer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2001
Immune evasion by muscle-specific gene expression in dystrophic muscleD Hartigan-O'Connor, C J Kirk, R Crawford, et al.
Nature|April 27, 1999
Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signallingJ Briscoe, L Sussel, P Serup, et al.
Cancer Research|March 31, 2001
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapyC J Kirk, D Hartigan-O'Connor, B J Nickoloff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2000
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectorsM A Hauser, A Robinson, D Hartigan-O'Connor, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Neurology|August 27, 2002
Progress toward gene therapy of Duchenne muscular dystrophyD Hartigan-O'Connor, J S Chamberlain
Microscopy Research and Technique|February 19, 2000
Developments in gene therapy for muscular dystrophyD Hartigan-O'Connor, J S Chamberlain
Journal of Virology|August 10, 1999
Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymeraseD Hartigan-O'Connor, A Amalfitano, J S Chamberlain
Cancer Research|December 26, 2001
The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodallyC J Kirk, D Hartigan-O'Connor, J J Mulé
Journal of Virology|February 23, 2000
Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stagesN H Shin, D Hartigan-O'Connor, J K Pfeiffer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2001
Immune evasion by muscle-specific gene expression in dystrophic muscleD Hartigan-O'Connor, C J Kirk, R Crawford, et al.
Nature|April 27, 1999
Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signallingJ Briscoe, L Sussel, P Serup, et al.
Cancer Research|March 31, 2001
T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapyC J Kirk, D Hartigan-O'Connor, B J Nickoloff, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2000
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectorsM A Hauser, A Robinson, D Hartigan-O'Connor, et al.
Pageof 1